Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-08

Clinical Trial Update: Elucidating the Neurocircuitry of Irritability With High-Field Neuroimaging to Identify Novel Therapeutic Targets [Phase 2]

View source ↗

Summary

A completed Phase 2 study that uses high-field neuroimaging to map the neural circuits linked to irritability in people with major depressive disorder. The goal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Major Depressive Disorder, Healthy Controls | Phase 2 | Status: COMPLETED